Credit Suisse Ag Chroma Dex Corp. Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.59 - $2.7 $39 - $67	25 New	25 $0
Q1 2021 May 14, 2021	SELL	$4.59 - $18.74 $60,344 - $246,374	-13,147 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.93 - $5.5 $51,667 - $72,308	13,147 New	13,147 $63,000
Q3 2018 Nov 13, 2018	SELL	$3.5 - $4.91 $44,940 - $63,044	-12,840 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.22 - $4.43 $41,344 - $56,881	12,840 New	12,840 $48,000
Q1 2018 May 15, 2018	SELL	$4.05 - $6.46 $66,897 - $106,706	-16,518 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.88 - $6.96 $64,089 - $114,965	16,518 New	16,518 $97,000
Q3 2017 Nov 14, 2017	SELL	$2.91 - $4.71 $161,158 - $260,844	-55,381 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	55,381	55,381 $211,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $402M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.